Millennium Management’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.57M | Buy |
1,101,342
+1,035,445
| +1,571% | +$1.48M | ﹤0.01% | 2792 |
|
|
2025
Q1 | $105K | Sell |
65,897
-294,228
| -82% | -$471K | ﹤0.01% | 3747 |
|
|
2024
Q4 | $1.3M | Buy |
360,125
+338,277
| +1,548% | +$1.22M | ﹤0.01% | 2751 |
|
|
2024
Q3 | $125K | Sell |
21,848
-487,558
| -96% | -$2.78M | ﹤0.01% | 3817 |
|
|
2024
Q2 | $2.35M | Sell |
509,406
-65,725
| -11% | -$304K | ﹤0.01% | 2395 |
|
|
2024
Q1 | $4.7M | Sell |
575,131
-157,014
| -21% | -$1.28M | ﹤0.01% | 2021 |
|
|
2023
Q4 | $4.14M | Sell |
732,145
-435,227
| -37% | -$2.46M | ﹤0.01% | 2016 |
|
|
2023
Q3 | $2.17M | Sell |
1,167,372
-968,225
| -45% | -$1.8M | ﹤0.01% | 2416 |
|
|
2023
Q2 | $5.87M | Buy |
2,135,597
+1,982,041
| +1,291% | +$5.45M | ﹤0.01% | 1824 |
|
|
2023
Q1 | $482K | Buy |
+153,556
| New | +$482K | ﹤0.01% | 3448 |
|
|
2022
Q3 | – | Sell |
-425,647
| Closed | -$3.21M | – | 5175 |
|
|
2022
Q2 | $3.21M | Sell |
425,647
-565,294
| -57% | -$4.26M | ﹤0.01% | 2510 |
|
|
2022
Q1 | $24M | Buy |
990,941
+237,550
| +32% | +$5.76M | 0.01% | 814 |
|
|
2021
Q4 | $24.3M | Buy |
753,391
+465,818
| +162% | +$15M | 0.01% | 875 |
|
|
2021
Q3 | $12.8M | Sell |
287,573
-96,975
| -25% | -$4.33M | 0.01% | 1256 |
|
|
2021
Q2 | $14.6M | Buy |
384,548
+205,480
| +115% | +$7.78M | 0.01% | 1072 |
|
|
2021
Q1 | $6.62M | Sell |
179,068
-375,500
| -68% | -$13.9M | ﹤0.01% | 1803 |
|
|
2020
Q4 | $18.4M | Buy |
+554,568
| New | +$18.4M | 0.01% | 846 |
|